| Basics |
Lantheus Holdings, Inc.
Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray imaging.
|
| IPO Date: |
June 25, 2015 |
| Sector: |
Healthcare |
| Industry: |
Medical Diagnostics and Research |
| Market Cap: |
$3.72B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.76 | 2.30%
|
| Avg Daily Range (30 D): |
$1.01 | 1.73%
|
| Avg Daily Range (90 D): |
$1.16 | 1.58%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.56M |
| Avg Daily Volume (30 D): |
1.75M |
| Avg Daily Volume (90 D): |
1.29M |
| Trade Size |
| Avg Trade Size (Sh.): |
66 |
| Avg Trade Size (Sh.) (30 D): |
62 |
| Avg Trade Size (Sh.) (90 D): |
52 |
| Institutional Trades |
| Total Inst.Trades: |
5,400 |
| Avg Inst. Trade: |
$3.28M |
| Avg Inst. Trade (30 D): |
$4.28M |
| Avg Inst. Trade (90 D): |
$4.2M |
| Avg Inst. Trade Volume: |
.06M |
| Avg Inst. Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.56M |
| Avg Closing Trade (30 D): |
$9.53M |
| Avg Closing Trade (90 D): |
$10.68M |
| Avg Closing Volume: |
102.14K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$3.93
|
$1.15
|
$1.06
|
|
Diluted EPS
|
$3.74
|
$1.12
|
$1.02
|
|
Revenue
|
$ 1.52B
|
$ 378.05M
|
$ 372.76M
|
|
Gross Profit
|
$ 969.38M
|
$ 241.01M
|
$ 237.7M
|
|
Net Income / Loss
|
$ 271M
|
$ 78.76M
|
$ 72.95M
|
|
Operating Income / Loss
|
$ 437.65M
|
$ 87.97M
|
$ 102.07M
|
|
Cost of Revenue
|
$ 551.27M
|
$ 137.03M
|
$ 135.06M
|
|
Net Cash Flow
|
$ -61.41M
|
$ -242.95M
|
$ 25.73M
|
|
PE Ratio
|
14.26
|
|
|
|
|
|
